Menu
/REGISTER
PPB
Fielding
Montecito
Powershare
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Beyond biologics: Amgen bets new drugs will pay dividend

By   /   Friday, May 6th, 2011  /   Comments Off on Beyond biologics: Amgen bets new drugs will pay dividend

Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.

    Print       Email

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

About the author

Chairman & Editor

You might also like...

Amgen sponsoring life science innovation hub called BioLA

Read More →